2Moja L,Tagliabue L,Balduzzi S,et al.Trastuzumab containing regimens for early breast cancer[J].Cochrane Database Syst Rev,2012,4:6.032. 被引量：1
3Perez EA,Suman VJ,Davidson NE,et al.Cardiacsafety analysis of doxorubicin and cyclopho sphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial[J].J Clin Oncol,2008,26(8):1231-1238. 被引量：1
4L Tarantini S,Gori P,Faggiano G,et al.Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer:a multicenter cohort analysis[J].Annals of oncology:official journal of the European Society for Medical Oncology/ESMO,2012,23(12):3058-63. 被引量：1
5Chen T,Xu T,Li Y,et al.Risk of cardiac dysfunction with trastuzumab in breast cancer pat-ients:a meta-analysis[J].Cancer T reat Rev,2014,37(4):312-320. 被引量：1
6Erin J Aiello,Bowles Robert,Wellman Heather Spencer,et al.Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment:a retrospective cohort study[J].Journal of the National Cancer Institute,2012,104(17):1293-305. 被引量：1
7Rohrbach S,Niemann B,Silber RE,et al.Neuregulin receptors erb B2 and erb B4 in failing human myocardium-depressed expression and attenuated activation[J].Basic Res Cardiol,2005,100(3):240-249. 被引量：1
8Chien KR.Herceptin and the heart-a molecular modifier of cardiac failure[J].N Engl J Med,2006,354(8):789-790. 被引量：1
9Bria E,Cuppone F,Milella M,et al.Trastuzumab cardio toxicity:biological hypotheses and clinical open issues[J].Expert Opin Biol Ther,2015,8(12):1963-1971. 被引量：1
10Guarneri V,Lenihan DJ,Valero V,et al.Long-term cardiac tolerability of trastuzumab in metastatic breast cancer:the M.D.Anderson Cancer Center experience[J].J Clin Oncol,2006,24(25):4107-4115. 被引量：1
二级参考文献6
1Slarnon DJ, Godolphin W, JonesL A, et al. Studies of the Her-2/neu proto-oncogene in human breast and ovarian cabcer [J]. Science,1989,244 (4905):707-712. 被引量：1
3Dent S, Verma SH, Latreille J, et al. The role of Her-2 targeted therapies in women with Her-2 overexpressing metastatic breast cancer [J]. Curt Oncol,2009,16(4):25-35. 被引量：1
4Baselga J, Norton L, Albanell J, et al. Recombinant humanized anti-Her-2 antibody (herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against Her-2/neu overexpressing human breast cancer xenografts [J]. Cancer Res,1998,58(13):2825-2830. 被引量：1
